跳至主要内容
临床试验/IRCT201507087373N5
IRCT201507087373N5已完成1 期

The efficacy of Vitamin D supplementation in the treatment of schizophrenia

Vice chancer for research , Arak University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 68 years(—)
性别
All

入选标准

  • diagnosis of schizophrenia according to DSM-5 criteria ,age range 18-68 ,a score of at least 60 in PANSS
  • Exclusion criteria:Mental Retardation; Organic brain disease; Parathyroid disorders; Use of Vitamin D Supplementation in recent 3 months; Pregnancy and Lactation; Vitamin D metabolism disorders; serum level of Vitamin D below 10 nmol/ml; serum level of Vitamin D over 100 nmol/ml; No interest to continue treatment; substance abuse; GFR below 60 ml/min; No response to previous treatment with Olanzapin; BMI over 30

排除标准

  • 未提供

研究者

发起方
Vice chancer for research , Arak University of Medical Sciences

相似试验